Progression free survival of first line vascular endothelial growth factor-targeted therapy is an important prognostic parameter in patients with metastatic renal cell carcinoma (Q57837650)
Jump to navigation
Jump to search
article by Christoph Seidel et al published May 2012 in European Journal of Cancer
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Progression free survival of first line vascular endothelial growth factor-targeted therapy is an important prognostic parameter in patients with metastatic renal cell carcinoma |
article by Christoph Seidel et al published May 2012 in European Journal of Cancer |
Statements
Progression free survival of first line vascular endothelial growth factor-targeted therapy is an important prognostic parameter in patients with metastatic renal cell carcinoma (English)
0 references
May 2012
0 references
48
0 references
7
0 references
1023-1030
0 references